• 1
    Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 2000;32: 377385.
  • 2
    Gross M, Steffes M, Jacobs DR Jr et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem 2005;51: 125131.
  • 3
    Keaney JF Jr, Larson MG, Vasan RS et al.; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23: 434439.
  • 4
    Block G, Dietrich M, Norkus EP et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002;156: 274285.
  • 5
    Dorjgochoo T, Gao YT, Chow WH et al. Obesity, age, and oxidative stress in middle-aged and older women. Antioxid Redox Signal 2011;14: 24532460.
  • 6
    Urakawa H, Katsuki A, Sumida Y et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003;88: 46734676.
  • 7
    Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114: 17521761.
  • 8
    Il'yasova D, Morrow JD, Wagenknecht LE. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res 2005;13: 16381644.
  • 9
    Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82: 4795.
  • 10
    Weyer C, Pratley RE, Salbe AD et al. Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab 2000;85: 10871094.
  • 11
    Zurlo F, Lillioja S, Puente Esposito-Del A et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990;259: E650E657.
  • 12
    Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord 1992;16: 667674.
  • 13
    Valtueña S, Salas-Salvadó J, Lorda PG. The respiratory quotient as a prognostic factor in weight-loss rebound. Int J Obes Relat Metab Disord 1997;21: 811817.
  • 14
    Marra M, Scalfi L, Contaldo F, Pasanisi F. Fasting respiratory quotient as a predictor of long-term weight changes in non-obese women. Ann Nutr Metab 2004;48: 189192.
  • 15
    Il'yasova D, Spasojevic I, Base K et al. Systemic markers of oxidative status and the risk of type 2 diabetes. Free Radical Biology and Medicine 2010;49: S38.
  • 16
    Yan W, Byrd GD, Ogden MW. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res 2007;48: 16071617.
  • 17
    Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 2008;10: 14051434.
  • 18
    Praticò D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001;12: 243247.
  • 19
    Dentchev T, Yao Y, Pratico D, Dunaief J. Isoprostane F2alpha-VI, a new marker of oxidative stress, increases following light damage to the mouse retina. Mol Vis 2007;13: 190195.
  • 20
    Wagenknecht LE, Mayer EJ, Rewers M et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995;5: 464472.
  • 21
    National Institute of Health (NIH) National Heart Lung, and Blood Institute's (NHLBI), North American Association for the Study of Obesity (NAASO). The practical guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publivation No 00-4084. 2000. Ref Type: Report.
  • 22
    Il'yasova D, Spasojevic I, Wang F et al. Urinary biomarkers of oxidative status in a clinical model of oxidative assault. Cancer Epidemiol Biomarkers Prev 2010;19: 15061510.
  • 23
    Meigs JB, Larson MG, Fox CS et al. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007;30: 25292535.
  • 24
    Davì G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005;7: 256268.
  • 25
    Basu S, Helmersson J, Jarosinska D et al. Regulatory factors of basal F(2)-isoprostane formation: population, age, gender and smoking habits in humans. Free Radic Res 2009;43: 8591.
  • 26
    Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976;29: 13591366.
  • 27
    Jones LW, Eves ND, Spasojevic I, Wang F, Il'yasova D. Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study. Lung Cancer 2011;72: 4551.
  • 28
    Rudra CB, Wactawski-Wende J, Hovey KM et al. Energy expenditure and plasma F2-isoprostanes across the menstrual cycle. Med Sci Sports Exerc 2011;43: 785792.
  • 29
    Cortright RN, Sandhoff KM, Basilio JL et al. Skeletal muscle fat oxidation is increased in African-American and white women after 10 days of endurance exercise training. Obesity (Silver Spring) 2006;14: 12011210.
  • 30
    Privette JD, Hickner RC, Macdonald KG, Pories WJ, Barakat HA. Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women. Metab Clin Exp 2003;52: 735738.
  • 31
    Chitwood LF, Brown SP, Lundy MJ, Dupper MA. Metabolic propensity toward obesity in black vs white females: responses during rest, exercise and recovery. Int J Obes Relat Metab Disord 1996;20: 455462.
  • 32
    Nicklas BJ, Berman DM, Davis DC, Dobrovolny CL, Dennis KE. Racial differences in metabolic predictors of obesity among postmenopausal women. Obes Res 1999;7: 463468.
  • 33
    Weyer C, Snitker S, Bogardus C, Ravussin E. Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr 1999;70: 1320.
  • 34
    Argyropoulos G, Brown AM, Willi SM et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 1998;102: 13451351.
  • 35
    Boss O, Samec S, Paoloni-Giacobino A et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997;408: 3942.